Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Evaluation of the Smad3 MH1 Domain as a novel effector of Retinoic Acid Action during Adipogenesis.

EF 2009-10

Résumé
Obesity in Canada is increasing, such that in 2015 there will be an estimated 63% of Canadians who are either obese or overweight. Obesity is a condition that results from an excess of body fat. This increased fat is associated with high cholesterol, high blood pressure and diabetes; and can cause complications such as strokes and heart attacks. Fat naturally secretes factors that help our body to control hunger, blood sugar and cholesterol. When fat is in excess, the amount of these factors increases, resulting in poor bodily function. Fat is stored in cells called adipocytes, and if an individual is over eating, more adipocytes can be produced through the production of new preadipocytes, to compensate for the increased nutrition. Overtime, this will result in the condition of obesity. It is known that a small decrease in the weight of an obese person can have a dramatically positive influence on their health, because of the improvements in blood sugar and cholesterol levels. Knowing that a small decrease in fat can have a positive influence, effecting strategies that make weight loss easier for obese individuals can have an enormous benefit to their health. Understanding the molecular basis of how fat cells are produced, can improve therapies directed to weight loss. Vitamin A is known to reduce fat in humans and animals. It also prevents fat cells from growing in our cultures in the laboratory. However, Vitamin A itself cannot be used in the treatment of obesity because it also affects body systems other than fat, causing serious side effects. Recently, our lab identified a protein that does Vitamin A's job in the cell and a small portion of this protein, called a peptide, is enough to prevent fat cell production. Through the use of advanced scientific techniques we will study this peptides effect on fat cell production. This peptide has the potential to be a new drug and it is our belief that it may one day be a possible treatment for obesity.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
201217
Name
Gunanayagam Angelo R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Evaluation of the Smad3 MH1 Domain as a novel effector of Retinoic Acid Action during Adipogenesis.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipogenesis; C/Ebp Beta; Chromatin Immunoprecipitation; Obesity; Protein-Protein Interactions; Smad3 Protein; Stem Cells; Tissue Culture; Transcription; Viral Transduction
Abstract
Obesity in Canada is increasing, such that in 2015 there will be an estimated 63% of Canadians who are either obese or overweight. Obesity is a condition that results from an excess of body fat. This increased fat is associated with high cholesterol, high blood pressure and diabetes; and can cause complications such as strokes and heart attacks. Fat naturally secretes factors that help our body to control hunger, blood sugar and cholesterol. When fat is in excess, the amount of these factors increases, resulting in poor bodily function. Fat is stored in cells called adipocytes, and if an individual is over eating, more adipocytes can be produced through the production of new preadipocytes, to compensate for the increased nutrition. Overtime, this will result in the condition of obesity. It is known that a small decrease in the weight of an obese person can have a dramatically positive influence on their health, because of the improvements in blood sugar and cholesterol levels. Knowing that a small decrease in fat can have a positive influence, effecting strategies that make weight loss easier for obese individuals can have an enormous benefit to their health. Understanding the molecular basis of how fat cells are produced, can improve therapies directed to weight loss. Vitamin A is known to reduce fat in humans and animals. It also prevents fat cells from growing in our cultures in the laboratory. However, Vitamin A itself cannot be used in the treatment of obesity because it also affects body systems other than fat, causing serious side effects. Recently, our lab identified a protein that does Vitamin A's job in the cell and a small portion of this protein, called a peptide, is enough to prevent fat cell production. Through the use of advanced scientific techniques we will study this peptides effect on fat cell production. This peptide has the potential to be a new drug and it is our belief that it may one day be a possible treatment for obesity.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gunanayagam, Angelo R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~